SWAV — Shockwave Medical Share Price
0.000.00%
Last trade - 00:00- $12.57bn
- $12.27bn
- $730.23m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 59.88 | ||
| PEG Ratio (f) | 2.82 | ||
| EPS Growth (f) | 26.96% | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 16.72 | ||
| Price to Tang. Book | 20.26 | ||
| Price to Free Cashflow | 75.65 | ||
| Price to Sales | 15.95 | ||
| EV to EBITDA | 71.04 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 10.38% | ||
| Return on Equity | 24.73% | ||
| Operating Margin | 20.43% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 42.93 | 67.79 | 237.15 | 489.73 | 730.23 | 928.03 | 1,132.68 | 126.45% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | -32.39 | +33.96 | +19.71 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Shockwave Medical, Inc. is a medical device company. The Company is primarily engaged in the development and commercialization of novel technologies that transform the care of patients with cardiovascular disease. The Company is focused on its intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular and heart valve disease. Built on a balloon catheter platform, the IVL technology uses lithotripsy to disrupt both superficial and deep vascular calcium., while minimizing soft tissue injury, and an integrated angioplasty balloon to dilate blockages at low pressures, restoring blood flow. Its Shockwave M5 IVL catheter and Shockwave M5+ IVL catheter are five-emitter catheters for use in its IVL System in medium-diameter vessels for the treatment of peripheral artery disease (PAD). Its Shockwave S4 IVL catheter is a four-emitter catheter for use in its IVL System in small-diameter vessels for the treatment of PAD.
Directors
- C. Raymond Larkin NEC (72)
- Douglas Godshall PRE (56)
- Daniel Puckett CFO (57)
- Isaac Zacharias OTH (46)
- Laura Francis IND (54)
- Frederic Moll IND (69)
- Maria Sainz IND (55)
- F. Thomas Watkins IND (68)
- Last Annual
- December 31st, 2023
- Last Interim
- March 31st, 2024
- Incorporated
- June 17th, 2009
- Public Since
- March 7th, 2019
- No. of Shareholders
- 16
- No. of Employees
- 1,468
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- NASDAQ Global Select Market
- Shares in Issue
- 37,543,542
- Address
- 5403 Betsy Ross Dr, SANTA CLARA, 95054
- Web
- https://shockwavemedical.com/
- Phone
- +1 5102794262
- Auditors
- Ernst & Young LLP
Upcoming Events for SWAV
Q2 2024 Shockwave Medical Inc Earnings Release
Q2 2024 Shockwave Medical Inc Earnings Call
Q3 2024 Shockwave Medical Inc Earnings Release
Q3 2024 Shockwave Medical Inc Earnings Call
Similar to SWAV
10X Genomics
NASDAQ Global Select Market
Accuray
NASDAQ Global Select Market
Akoya Biosciences
NASDAQ Global Select Market
Align Technology
NASDAQ Global Select Market
Alphatec Holdings
NASDAQ Global Select Market
FAQ
What is the Shockwave Medical share price?
As of Today at 23:15 UTC, shares in Shockwave Medical are trading at $334.75. This share price information is delayed by 15 minutes.
How has the Shockwave Medical share price performed this year?
Shares in Shockwave Medical last closed at $334.75 and the price had moved by +21.69% over the past 365 days. In terms of relative price strength the Shockwave Medical share price has underperformed the S&P500 Index by -1.26% over the past year.
What are the analyst and broker recommendations for Shockwave Medical?
The overall consensus recommendation for Shockwave Medical is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Shockwave Medical dividend yield?
Shockwave Medical does not currently pay a dividend.
Does Shockwave Medical pay a dividend?
Shockwave Medical does not currently pay a dividend.
When does Shockwave Medical next pay dividends?
Shockwave Medical does not currently pay a dividend.
How do I buy Shockwave Medical shares?
To buy shares in Shockwave Medical you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Shockwave Medical?
As of the previous close price of $334.75, shares in Shockwave Medical had a market capitalisation of $12.57bn.
Where are Shockwave Medical shares listed?
Here are the trading details for Shockwave Medical:
- Country of listing: United States
- Exchange: NSQ
- Ticker Symbol: SWAV
What kind of share is Shockwave Medical?
Based on an overall assessment of its quality, value and momentum Shockwave Medical is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Shockwave Medical share price forecast for 2024?
The analyst consensus target price for shares in Shockwave Medical is $324.27. That is 3.13% below the last closing price of $334.75.
Analysts covering Shockwave Medical currently have a consensus Earnings Per Share (EPS) forecast of $5.16 for the next financial year.
Find out moreWhat is the trend in the Shockwave Medical share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Shockwave Medical. Over the past six months, its share price has outperformed the S&P500 Index by +59.09%.
As of the last closing price of $334.75, shares in Shockwave Medical were trading +39.16% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Shockwave Medical PE Ratio?
The Shockwave Medical PE ratio based on its reported earnings over the past 12 months is 59.88. The shares last closed at $334.75.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Shockwave Medical?
Shockwave Medical's management team is headed by:
- C. Raymond Larkin - NEC
- Douglas Godshall - PRE
- Daniel Puckett - CFO
- Isaac Zacharias - OTH
- Laura Francis - IND
- Frederic Moll - IND
- Maria Sainz - IND
- F. Thomas Watkins - IND